WELLINGTON –
A 10-month-old infant, Autumn, has died at Wellington Hospital following a medical struggle with MIRAGE syndrome, an exceptionally rare genetic condition.
The case highlights the intersection of rare disease pathology and the utilization of digital crowdfunding platforms to manage the financial exigencies associated with terminal pediatric care and subsequent memorial arrangements. It also underscores the pressures on publicly funded health systems when ultra-rare conditions require prolonged specialist treatment and family support.
Clinical Profile of MIRAGE Syndrome
MIRAGE syndrome is a rare genetic condition affecting approximately one in 1 million infants. The disorder is caused by a mutation in the SAMD9 gene, which impacts multiple systemic functions, often requiring coordinated care across paediatric, endocrine, haematology and gastroenterology services.
The syndrome is characterized by several primary clinical features:
- Myelodysplasia (bone marrow complications)
- Infections
- Restriction of growth
- Adrenal hypoplasia (underdeveloped adrenal glands)
- Genital abnormalities
- Enteropathy (gut complications)
Because of its complexity and rarity, MIRAGE syndrome typically necessitates repeated hospitalisations, intensive monitoring and access to genetic diagnostics that sit at the specialised end of services funded under New Zealand’s publicly financed health system, now overseen nationally by Te Whatu Ora – Health New Zealand.
Family Account and Medical Timeline
Autumn’s parents and six-year-old brother spent “countless days and nights” at Wellington Hospital during the 10 months of her life. The family stated they took every possible measure to provide her with “every chance possible,” working closely with clinicians as treatment options were explored and her condition fluctuated.
“Unfortunately, her body had been through so much she couldn’t fight anymore. She passed peacefully in our arms surrounded by her family.”
The family further described the infant’s impact on their lives: “Despite everything she endured, she filled our lives with so much love, strength, and joy. Her smile, her courage, and the love she gave us in her short life will stay with us forever.”
Crowdfunding, Public Health and Memorial Funding
Following the death, the family established a fundraising presence on Givealittle, a New Zealand-based crowdfunding platform. The initiative was created following encouragement from friends to assist in covering memorial costs and ongoing expenses, including time away from work and costs not fully met through the public system.
While hospital care for children is generally covered under New Zealand’s universal health arrangements, families facing prolonged end-of-life care for rare conditions frequently turn to community fundraising to bridge gaps around travel, accommodation, lost income and funeral costs. Platforms such as Givealittle operate within New Zealand’s wider charitable and consumer framework, which is underpinned in part by the Charities Act 2003.
The family issued a statement regarding the support: “Thank you for your kindness, generosity, and for helping us celebrate the beautiful life of our precious Autumn. She will always be deeply loved, forever missed, and never forgotten.”
The family is currently in the process of planning a memorial service.
Official status: Memorial planning and Givealittle fundraising ongoing.
Related reading
